PineBridge Investments’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41.4M Buy
184,320
+41,464
+29% +$10.3M 0.35% 55
2025
Q4
$34.4M Buy
142,856
+3,787
+3% +$968K 0.25% 77
2025
Q3
$38.1M Sell
139,069
-44,744
-24% -$12.2M 0.28% 79
2025
Q2
$47.4M Buy
183,813
+40,183
+28% +$9.59M 0.38% 55
2025
Q1
$32.2M Buy
143,630
+20,037
+16% +$4.68M 0.26% 83
2024
Q4
$28.3M Buy
123,593
+74,408
+151% +$17.9M 0.21% 102
2024
Q3
$12M Buy
49,185
+13,258
+37% +$2.96M 0.09% 203
2024
Q2
$6.88M Buy
35,927
+4,955
+16% +$1.01M 0.06% 264
2024
Q1
$6.13M Buy
30,972
+19,097
+161% +$3.5M 0.05% 312
2023
Q4
$2.04M Buy
11,875
+2,951
+33% +$453K 0.02% 370
2023
Q3
$1.32M Buy
8,924
+8,020
+887% +$1.45M 0.01% 414
2023
Q2
$198K Buy
904
+273
+43% +$60.8K ﹤0.01% 537
2023
Q1
$138K Buy
+631
New +$137K ﹤0.01% 527
2021
Q2
Sell
-8,463
Closed -$1.64M 681
2021
Q1
$1.64M Sell
8,463
-24,924
-75% -$5M 0.02% 475
2020
Q4
$7.1M Buy
33,387
+11,236
+51% +$2.24M 0.11% 220
2020
Q3
$3.8M Sell
22,151
-23,316
-51% -$4.31M 0.07% 280
2020
Q2
$8.73M Buy
+45,467
New +$7.44M 0.17% 150

Other funds holding RMD

PineBridge Investments's RMD Position: Q1 2026 in Review

PineBridge Investments increased its ResMed (RMD) stake by 29% in Q1 2026, buying an estimated $10.3M and bringing the position to 184,320 shares worth $41.4M. The position accounts for 0.35% of the portfolio, ranked #55.

PineBridge Investments first reported a position in RMD in Q2 2020 and has held it in 17 quarters since. The position peaked at $47.4M in Q2 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • PineBridge Investments held 184,320 shares of ResMed worth $41.4M as of Q1 2026.
  • PineBridge Investments bought 41,464 ResMed shares in Q1 2026, an estimated $10.3M.
  • ResMed made up 0.35% of PineBridge Investments's portfolio in Q1 2026, its #55 holding.
  • PineBridge Investments first reported a position in ResMed in Q2 2020 and has held it in 17 quarters since.
  • PineBridge Investments's ResMed position peaked at $47.4M in Q2 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on PineBridge Investments's 13F filing for Q1 2026, filed 14 May 2026.